Link between heart disease, cholesterol, and Alzheimer's disease: A review

Microscopy Research and Technique

Volumn 50, Issue 4, 2000, Pages 287-290

  Sparks, D Larry ^a,d   Martin, Timothy A ^a   Gross, David R ^b   Hunsaker III, John C ^c,d  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d Div of Medical Examiner's Services   (United States)

Author keywords

AD; Cholesterol; Heart disease

Indexed keywords

CHOLESTEROL; GLYCOPROTEINS; HEART; NEURODEGENERATIVE DISEASES;

AD; ALZHEIMERS DISEASE; AMYLOID DEPOSITS; CORONARY HEART DISEASE; CULTURE CELLS; HEART DISEASE; INCREASE PRODUCTIONS; NEUROPIL; RABBIT MODELS; REDUCTASE INHIBITORS;

CARDIOLOGY;

AMYLOID BETA PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;

ALZHEIMER DISEASE; CHOLESTEROL DIET; ENZYME ACTIVITY; HYPERTENSION; ISCHEMIC HEART DISEASE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROVOCATION TEST; REVIEW; SENILE DEMENTIA; SENILE PLAQUE; TRANSGENIC MOUSE;

MUS MUSCULUS; ORYCTOLAGUS CUNICULUS;

EID: 0034663175     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0029(20000815)50:4<287::AID-JEMT7>3.0.CO;2-L     Document Type: Review

References (38)

1. Bodovitz S, Klein WL. 1996. Cholesterol modulates alpha-secretase cleavage of amyloid procursor protein. J Biol Chem 271:4436-4440.
2. Cataldo AM, Hamilton DJ, Nixon RA. 1994. Lysosomal abnormalities in degenerating neurons link neuronal comprimise to senile plaque development in Alzheimer disease. Brain Res 640:68-80.
3. Durham RA, Parker CA, Emmerling MR, Bisgaier CL, Walker LC. 1998. Effect of age and diet on the expression of beta-amyloid 1-40 and 1-42 in the brains of apolipoprotein-E-deficient mice. Neurobiol Aging 19:8281.
4. Fishman CE, White SL, DeLong CA, Cummins DJ, Jordan WH, Bales KR, Paul SM. 1999. High fat diet potentiates β-amyloid deposition in the APP V717F transgenic mouse model of Alzheimer's disease. Soc Neurosci 25:1859.
5. Frears ER, Stephens DJ, Walters CE, Davies H, Austen BM. 1999. The role of cholesterol in the biosynthesis of β-amyloid. NeuroReport 10:1699-1705.
6. Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. 1999. Current and remote blood pressure and cognitive decline. JAMA 281:438-445.
7. Haas U, Sparks DL. 1996. Cathepsin D: Activity and immunocytochemical localization in Alzheimer's disease and aging. Mol Chem Neuropathol 29:1-14.
8. Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, Maeda N, Siman R, Greenberg BD, Scott RW, Flood DG. 1998. Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem 273:16576-16582.
9. Hyman BT, Marzloff K, Arriagada PV. 1993. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropath Exp Neurol 52:594-600.
10. Killander L, Nyman H, Boberg M, Hansson L, Lithell H. 1988. Hypertension is related to cognitive impairment: A 20-year follow-up of 999 men. Hypertension 31:780-786.
11. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. 1995. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia aging study. JAMA 274:1846-1851.
12. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ. 2000. Mid-life blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 49-55.
13. Li L, Zeigler S, Lindsey RJ, Fukuchi K. 1999. Effects of an atherogenic diet on amyloidosis in transgenic mice overexpressing the C-terminal portion of β-amyloid precursor protein. Soc Neurosci 25:1859.
14. McKhann GM, Goldsborough MA, Borowicz LM, Selnes OA, Mellits ED, Enger C, Quaskey SA, Baumgartner WA, Cameron DE, Stuart RS, Gardner TJ. 1997. Cognitive outcome after coronary artery bypass: A one-year prospective study. Ann Thorac Surg 63:510-515.
15. Nixon RA, Cataldo AM, Mathews PM, Mohan P, Golumb J. 1998. Abnormalities of the Endosomal-Lysosomal system in Alzheimer's disease as potential therapeutic targets. Neurobiol Aging 19:S136-S137.
16. Onat A, Dursunoglu D, Aktuglu G. 1994. Homozygous factor X deficiency associated with familial hypercholesterolemia, mitral valve prolapse, and hypertrophic cardiomyopathy. Acta Haematol 91:66-69.
17. Petrovitch H, White LR., Izmirilian G, Ross GW, Havlik RJ, Markesbery WR, Nelson J, Davis DG, Hardman J, Foley DJ, Launer LJ. 2000. Mid-life blood pressure and neuritic plaques, neurofibrillary tangles and brain weight ant death: The HAAS. Neurobiol Aging 21:57-62.
18. Prince M, Cullen M, Mann A. 1994. Risk factor for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 44:97-104.
19. Racchi M, Baetta R, Salvietti N, Ianna P, Franceschini G, Pacletti R, Fumagalli R, Govoni S, Trabucchi M, Soma M. 1997. Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J 322:893-898.
20. Shie FS, LeBoeuf RC, Leverenz JB, Jin LW. 1999. Effects of cholesterol feeding on histopathologic hallmarks of Alzheimer's disease in β-amyloid precursor protein (APP) transgenic mice. Soc Neurosci 25:1859.
21. Shih DM, Welch C, Lusis AJ. 1995. New insights into atherosclerosis from studies with mouse models. Mol Med Today 364-372.
22. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. 1998. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci USA 95:6460-6464.
23. Skoog I. 1999. The interaction between vascular factors and Alzheimer's disease. In: Alzheimer's disease and related disorders. Etiology, pathogenisis and therapeutics. K Iqbal, DF Swaab, and HM Wisniewski, editors. New York: John Wiley & Sons, p 523-530.
24. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Oden A, Svanborg A. 1996. 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145.
25. Soneira CF, Scott TM. 1996. Severe cardiovascular disease and Alzheimer's disease: Senile plaque formation in cortical areas. Clin Anat 9:118-127.
26. Sparks DL. 1996. Intraneuronal β-amyloid immunoreactivity in the CNS. Neurobiol Aging 17:291-299.
27. Sparks DL. 1997. Dietary cholesterol induces Alzheimer-like β-amyloid immunoreactivity in rabbit brain. Nutr Metab Cardiovasc Dis 7:255-266.
28. Sparks DL. 1999. Neuropathologic links between Alzheimer's disease and Vascular disease. In: Iqbal K, DF Swaab, and HM Wisniewski, editors. Alzheimer's Disease and Related Disorders, vol. 6. New York: John Wiley & Sons, p 153-163.
29. Sparks DL, Hunsaker JC, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR. 1990. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11:601-607.
30. Sparks DL, Liu H, Scheff SW, Coyne CM, Hunsaker JC III. 1993.Temporal sequence of plaque formation in the cerebral cortex of nondemented individuals. J Neuropath Exp Neurol 52:135-142.
31. Sparks DL, Scheff SW, Liu H, Landers T, Coyne CM, Hunsaker JC. 1995a. Increased density of neurofibrillary tangles (NFT) in nondemented individuals with hypertension. J Neurolog Sci 131:162-169.
32. Sparks DL, Liu H, Gross DR, Scheff SW. 1995b. Increased density of cortical Apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol. Neurosci Lett 187:142-144.
33. Sparks DL, Kou Y-M, Roher A, Martin TA, Lukas RJ. 1999. Alterations of Alzheimer's disease in the cholesterol-fed rabbit, including vascular inflammation. Preliminary observations. NY Acad Sci 903: 335-344.
34. Sparks D.L, Gross DR, Hunsaker III JC. 2000. Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs. Neurobiol Aging (in press).
35. Streit WJ, Sparks DL. 1997. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J Mol Med 75:130-138.
36. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D. 1998. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 51:986-993.
37. Urmoneit B, Turner J, Dyrks T. 1998. Cationic lipids (lipofectamine) and disturbance of cellular cholesterol and sphinglmyelin distribution modulates gamma-secretase activity within amyloid precursor protein in vitro. Prostoglandins Other Lipid Metiat 55:331-343.
38. Wolozin B, Kellman W, Celesia GG, Siegel G. 1999. Decreased prevalence of Alzheimer's disease associated with HMG-CoA reductase inhibitors. Soc Neurosci 26:16.